Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Investor Presentation 2026

May 15, 2026

62222_rns_2026-05-15_690d5ee5-2a0b-4e7c-9f4d-f6eb3404882f.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

HESTER

Hester Biosciences Limited
HQ and Registered Office
Village Meda-Adraj
Taluka Kadi
District Mehsana
Gujarat 384441, India
Phone +91 2764 285 502
+91 2764 285 453

Ahmedabad Office
Pushpak, 1st Floor
Panchvati Circle
Motilal Hirabhai Road
Ahmedabad 380006
Gujarat, India
Phone +91 79 264 45106

Email [email protected]
www.hester.in
CIN L99999GJ1987PLC022333

15 May 2026

To,
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai 400 001

Scrip Code: 524669

To,
National Stock Exchange of India Limited
Exchange Plaza,
Bandra - Kurla Complex,
Bandra (E), Mumbai 400 051

Symbol: HESTERBIO

Dear Sir/ Madam:

Subject: Announcement under Regulation 30 (LODR) - Corporate Presentation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Corporate Presentation of the Company for FY 2025-26.

The aforesaid presentation is also available on the website of the Company at:
https://www.hester.in/hester-presentation

This is for your information and records.

Sincerely
For Hester Biosciences Limited

Vinod Mali
Digitally signed by Vinod Mali
Date: 2026.05.15
16:58:52 +05'30'

Vinod Mali
Company Secretary & Compliance Officer

Enclosure: As above


HESTER

Hester Biosciences Limited

Corporate Presentation

2025-2026

Serving Animal Health Since 1997

www.hester.in


HESTER

MISSION

Better health for human beings through healthier animals

VISION

Building the future on a foundation of excellence

CORE VALUES

Integrity • Innovation • Passion
Discipline • Trust


HESTER

EXECUTIVE LEADERSHIP

img-0.jpeg

Rajiv Gandhi

CEO & Managing Director

Hester Biosciences was founded by Rajiv Gandhi. Since launching a single vaccine in 1997, he has led the company to become one of Asia's largest animal vaccine producers. Through strategic diversification and a deep understanding of the evolving business landscape, he has transformed Hester into a leading force in animal healthcare.

He serves as President of Ahmedabad Management Association (AMA). He has served as a member on the National Advisory Committee for the Animal Husbandry and Dairying Sector constituted by the Government of India and also as Chairman of FICCI Gujarat State Council. He remains associated with leading academic institutions.

In recognition of his entrepreneurial vision and contribution to the industry, he was conferred the Outstanding Entrepreneur of the Year award by Ahmedabad Management Association (AMA) in 2016.

He believes investing in science, people and systems, he addresses evolving market needs while shaping the future of animal healthcare.

img-1.jpeg

Priya Gandhi

Executive Director

Priya Gandhi serves as the Executive Director of Hester Biosciences Limited. Associated with Hester since 2016, she has steered the Company's strategic direction and business expansion while institutionalising cross-functional integration across businesses and subsidiaries and fostering strategic partnerships. She also strengthens organisational effectiveness through corporate policy formulation and governs their end-to-end execution and adherence.

Her undergraduate degree from Srishti Manipal Institute of Art, Design and Technology equips her to direct the Company's corporate communications and branding, while her Postgraduate degree in Management for Family Business from the Indian School of Business (ISB), Hyderabad complements her role in driving and managing business expansion initiatives.

Her endeavor remains to bring transformative healthcare solutions that serve animals, empower farmers and support the vision of One Health globally.


HESTER

39 Years
Legacy in animal health

3,325.99 INR Mn
Consolidated revenue FY 2025-26

3 Manufacturing Plants
India | Nepal | Africa

35+ Countries
Global footprint


HESTER

img-2.jpeg

OUR CORE OFFERINGS

img-3.jpeg

Biologicals

Live vaccines and Inactivated vaccines

img-4.jpeg

Feed Supplements

Mineral and Vitamin supplements, Immunity booster, Toxin binders, Growth promoters, Energy supplements, Nutritional supplement for Gut Health and Liver Care

img-5.jpeg

img-6.jpeg

img-7.jpeg

img-8.jpeg

Biosecurity

Farm Hygiene, disinfectants, water purifiers and Teat dipping solutions

img-9.jpeg

Therapeutics

Advance range of antibiotics for mastitis and uterine infections, Anti-inflammatory, Anti-diarrhoeal, Dewormers and Parasiticides

World's largest supplier of PPR vaccine
Supplier to the WOAH PPR vaccine bank
Leading LSD vaccine supplier across Africa


HESTER

Corporate Headquarters,
Flagship R&D and Manufacturing Plant

Capacity : 8.6 Billion Doses (Annually)
Employee Strength : 500+

Hester India, Mehsana, Gujarat

WHO-GMP, GLP and ISO 9001:2015,
ISO 14001:2015 and ISO 45001:2018


HESTER

HESTER INDIA

img-10.jpeg

Network

● Sales Depots 15
Distributors 1,000+
Field Force 250+

HESTER

DIVISIONS

img-11.jpeg

Poultry Healthcare

Vaccines, medicines and supplements for poultry

img-12.jpeg

Animal Healthcare

Vaccines, medicines and supplements for Ruminants and Companion animals


HESTER

POULTRY HEALTHCARE

Vaccines

  • Newcastle Disease
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Low Pathogenic Avian Influenza
  • Marek's Disease
  • Fowl Pox
  • Inclusion Body Hepatitis
  • Infectious Coryza
  • Fowl Cholera
  • Egg Drop Syndrome
  • Reo
  • Fowl Typhoid (Salmonella)
  • Avian Encephalomyelitis

Health Products

Feed Supplements

  • Effiboost: 2XD3
  • Decarnitox: Toxcinil Plus
  • Hestacid P
  • Hestflora
  • Hestbac: AmmoStop

Therapeutics

  • Xester BH
  • CuRx Oral
  • Iceft 4g
  • Hestdox N

Biosecurity

  • Klorclean
  • Instakol Plus
  • Kleanoxone
  • Silvectant

HESTER

POULTRY HEALTHCARE PRODUCTS

img-13.jpeg


HESTER

ANIMAL HEALTHCARE

LARGE AND SMALL RUMINANTS

img-14.jpeg

Vaccines

  • PPR
  • Goat Pox
  • LSD (Lumpy Skin Disease)
  • CBPP
  • CCPP
  • Brucella
  • PPR GPV

Health Products

Feed Supplements

  • ProtinC
  • ProtinC Keto*
  • ReproPlus Gold (RPG)
  • Bovitone HQ₁₀
  • Inomilk Gel
  • Catabuff

Therapeutics

  • CuRx LA Injection
  • ICEFT RTU
  • Amastic Range
  • ChekB Range
  • Clomecvet

Biosecurity

  • Post M

Note

Includes vaccine produced at Hester Africa and Hester Nepal


HESTER

ANIMAL HEALTHCARE PRODUCTS

LARGE AND SMALL RUMINANTS

img-15.jpeg


HESTER

ANIMAL HEALTHCARE

COMPANION ANIMALS

img-16.jpeg

Health Products

Feed Supplements

  • TumOnzym
  • Synoton
  • HestaLiv
  • VitaCoat
  • VitaCoat Advance

Therapeutics

  • Hestacef CV
  • CefShot Tazo
  • HestaFlam
  • Safeline Spot On
  • WormPeril

Cosmetics

  • PetsGlow
  • PawFresh

HESTER

ANIMAL HEALTHCARE PRODUCTS

COMPANION ANIMALS

img-17.jpeg
HestaCef™ CV

img-18.jpeg
VitaCoat® Advance

img-19.jpeg
Safeline

img-20.jpeg
TumOnzym™

img-21.jpeg
PawFresh


HESTER

img-22.jpeg

Hester Nepal, Nala Ugrachandi, Kathmandu

Manufacturing Plant

Capacity : 1.24 Billion Doses (Annually)
Employee Strength : 40+

GMP Certification (DDA Nepal), AU-PANVAC
Quality Certification and ISO 9001:2015


HESTER

img-23.jpeg

Hester Africa, Kibaha, Tanzania

Manufacturing Plant

Capacity: 1.5 Billion Doses (Annually)
Employee Strength: 60

GMP Accreditation (TMDA Tanzania)


GALV

Protecting Livestock - Imp

Strangthering Rum

Vaccine

HESTER

img-24.jpeg

GALVmed - HESTER AFRICA PARTNERSHIP

VITAL 2 PROJECT

Veterinary Innovations Transforming Animal Health and Livelihoods 2 (VITAL 2) project aims to enable sustainable market-driven ruminant vaccine delivery, increase ruminant vaccine adoption and coverage and improve ruminant livestock health across Kenya, Nigeria and Tanzania for small scale producers (SSPs).

The programme is to scale up ruminant vaccine availability and accessibility at a national level while also working in targeted exemplar areas and production systems as entry points.


HESTER

STANDALONE DIVISIONAL REVENUE

April 2025 - March 2026

Poultry Healthcare 206.13 71%
Animal Healthcare 86.01 29%
Total 292.14 100%

img-25.jpeg

CONSOLIDATED DIVISIONAL REVENUE

April 2025 - March 2026

Poultry Healthcare 205.97 62%
Animal Healthcare 126.63 38%
Total 332.60 100%

img-26.jpeg

Values in INR Cr


HESTER

HESTER BIOSCIENCES

Financial Performance

img-27.jpeg

Values in INR Cr


HESTER

OVERALL BUSINESS HIGHLIGHTS

Largest supplier of PPR vaccine to the world
Supplier to the PPR WOAH vaccine bank

Largest supplier of LSD vaccine to African countries and Central Asia

Largest supplier of Goat Pox Vaccine in India to immunize cattle against LSD

Second largest poultry vaccine manufacturer in India having 35% market share

Ongoing R&D towards increasing vaccine & health products range

Focussing on expanding the Petcare division in India


img-28.jpeg

Better health for human beings through healthier animals